中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Volume 36 Issue 5
May  2020
Turn off MathJax
Article Contents

Clinical and biochemical features of bile duct injury type of drug-induced liver injury

DOI: 10.3969/j.issn.1001-5256.2020.05.022
Research funding:

 

  • Published Date: 2020-05-20
  • Objective To investigate the pathological and biochemical features of each pathological subtype of bile duct injury type of drug-induced liver injury(DILI), and to verify the value and significance of pathological classification of DILI.Methods A retrospective analysis was performed for the clinical data of 112 patients with bile duct injury type of DILI who were admitted to Shijiazhuang Fifth Hospital from January 2006 to January 2016 and China-Japan Friendship Hospital from October 2003 to June 2014. According to the pathological subtype, the patients were divided into mixed hepatitis group with 40 patients, cholestatic hepatitis group with 40 patients, and simple cholestasis group with 32 patients, and the three groups were compared in terms of types of drugs used, course of disease, R value, and peak values,changing trend, time to peak, and recovery time of liver biochemical indices. The independent-samples Kruskal-WallisHtest was used for comparison of continuous data between multiple groups, and the Mann-WhitneyUtest was used for further comparison between two groups; the chi-square test was used for comparison of categorical data between groups.Results Among the drugs inducing DILI, traditional Chinese medicine and Western medicine each accounted for half of the cases of bile duct injury type of DILI. Traditional Chinese medicine mainly included the drugs for osteoarthropathy, intervertebral disc bulge, alopecia, calculus-removing and cholagogic treatment,Yang-tonifying therapy, and skin diseases; 26 patients(65%) in the cholestatic hepatitis group had DILI caused by traditional Chinese medicine, while 16 patients(40%) in the mixed hepatitis group and 13(40.6%) in the simple cholestasis group had such DILI. Antibiotics and antipyretic and analgesic drugs were the most common Western medicines for DILI. The mixed hepatitis group had the highest peak values of ALT and AST and R value, followed by the cholestatic hepatitis group and the simple hepatitis group (χ2 =54. 77, 44. 21, and5195, allP< 0. 001), and there were no significant differences in the peak values of the other liver biochemical parameters between the three groups(allP> 0. 05). In the mixed hepatitis group and the cholestatic hepatitis group, the time to peak of TBil was longer than that of ALT. There were no significant differences in course of disease, time to peak of liver biochemical parameters, and recovery time between the three groups(allP> 0. 05).Conclusion Each subtype of bile duct injury type of DILI has unique clinical and biochemical features,and an understanding of such features may help to accurately judge clinical typing, pathological changes of targets, and degree of injury.

     

  • loading
  • [1] BENICHOU C. Criteria of drug-induced liver disorders. Report of an international consensus meeting[J]. J Hepatol,1990, 11(2):272-276.
    [2] Drug-induced liver injury group of the liver Department of the Chinese Medical Association. Interpretation of CSH clinical guideline:The diagnosis and management of drug-induced liver injury[M]. Shanghai:Shanghai Science and Technology Press, 2015:21-22.(in Chinese)中华医学会肝脏病学分会药物性肝损伤组.物性肝损伤诊治指南解读[M].上海:上海科学技术出版社,2015:21-22.
    [3] WANG TL, ZHAO XY, SHAO C, et al. A proposed pathologic sub-classification of drug-induced liver injury[J]. Hepatol Int, 2019, 13:339-351.
    [4] SHEN T, HUANG X, WANG YY, et al. Current status of epidemiological studies on drug-induced liver injury in China[J]. J Clin Hepatol, 2018, 34(6):1152-1155.(in Chinese)沈弢,黄昕,王誉雅,等.我国药物性肝损伤流行病学研究现状[J].临床肝胆病杂志,2018, 34(6):1152-1155.
    [5] YANG H, WANG XQ, BAI YQ. Clinical analysis of 115 patients with drug-induced liver disease[J]. J Medical Forum, 2010,31(8):70-74.(in Chinese)杨惠,王修齐,白阳秋.药物性肝损伤115例临床分析[J].医药论坛杂志,2010, 31(8):70-74.
    [6] HU Q, LIU W, SHAO H. Research progress of pharmacotherapy drug-induced liver injury[J]. Chin J Clin Pharmacol Ther, 2016, 21(2):231-236.(in Chinese)胡琴,刘维,邵宏.药物性肝损伤的药物治疗研究进展[J].中国临床药理学与治疗学,2016, 21(2):231-236.
    [7] HE WP, XU B, WANG HF, et al. Correlation between clinical classification and histopathology in drug-induced liver injury[J]. Chin Hepatol, 2010, 15(4):241-243.(in Chinese)何卫平,许彪,王慧芬,等.药物性肝病临床分型和病理相关性分析[J].肝脏,2010, 15(4):241-243.
    [8] YU YC, HE CL. The prognosis of hepatic injury and Live tissue repair[J]. Chin Hepatol, 2010, 15(6):460-464.(in Chinese)于乐成,何长伦.肝损伤转归与肝组织修复[J].肝脏,2010,15(6):460-464.
    [9] MEHENDALE HM. Tissue repair:An important determinant of final outcome of toxicant-induced injury[J]. Toxicol Pathol,2005, 33(1):41-51.
    [10] SUZAKI Y, KATAGIRL H, WANG T, et al. Ductular reaction in the liver regenerantin process with local inflammation after physical partial hepatectomy[J]. Lab Invest, 2016, 96(11):1211-1222.
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Article Metrics

    Article views (859) PDF downloads(155) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return